Considering that our data was collected from a single medical center and only contained COAD cases with TNM stage III, we further investigated the role of DTWD2 in the TCGA cohort, which contains 41 normal colon specimens and 478 COAD specimens. Here, DTWD2 is linked to colon adenocarcinoma.